Wellvone (Atovaquone Oral Suspension) 750mg/5ml*226ml

Wellvone (Atovaquone) is an antiprotozoal oral suspension used for treating and preventing specific infections like pneumocystis pneumonia (PCP) and toxoplasmosis. This 750mg/5ml strength suspension comes in a 226ml bottle, suitable for patients requiring liquid formulations. Store at ambient temperature for convenience.

Strength

750mg/5ml*226ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

GlaxoSmithKline Pharmaceuticals Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Wellvone (Atovaquone) is primarily used to treat and prevent pneumocystis pneumonia (PCP), a type of lung infection common in immunocompromised individuals. It is also prescribed for toxoplasmosis, an infection caused by a parasite. The oral suspension form is ideal for patients who have difficulty swallowing tablets. Always consult a healthcare provider to determine if this medication is appropriate for your condition.

Side Effects

Wellvone (Atovaquone) works by interfering with the parasite's ability to produce energy, which helps control the infection. Common effects may include nausea, headache, or rash, though these vary by individual. The suspension is absorbed gradually, providing steady medication levels in the body. Most users tolerate it well when taken as directed.

Precautions & Warnings

Store Wellvone (Atovaquone) oral suspension at room temperature, away from moisture and heat. Keep the bottle tightly closed when not in use to maintain potency. Avoid freezing the suspension, as this can alter its consistency. Always check the expiration date before use and dispose of any unused medication properly.

Avoid Interactions

Wellvone (Atovaquone) may interact with certain medications, including rifampin, rifabutin, and metoclopramide, which can reduce its effectiveness. Antacids containing aluminum or magnesium may also interfere with absorption if taken simultaneously. Always inform your healthcare provider about all medications and supplements you are using to avoid potential interactions.

Frequently Asked Questions

Wellvone is used to treat and prevent pneumocystis pneumonia (PCP) and toxoplasmosis in immunocompromised patients.

Store at room temperature, away from moisture and heat, and avoid freezing the suspension.

Consult your healthcare provider before combining Wellvone with other drugs to avoid potential interactions.

Common effects may include nausea, headache, or rash, though these vary by individual.

Yes, Wellvone is formulated as an oral suspension and is not available in tablet form.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.